The Impact of IgG4-RD on Patients’ Mental Health
“The best way to support patients’ mental health needs is to connect them with resources and other professionals.” Hear more from Parastoo Fazeli, MD on the impact of IgG4-RD on patients’ mental health. Read Q&A >
IgG4-RD and the Diagnostic Odyssey: Q&A With Leonard Calabrese, DO
IgG4-RD is a rare and complex immune disorder that was officially recognized as a disease only about two decades ago. It often looks like a range of other diseases, so it can take several years to diagnose properly. Awareness and understanding is the key to earlier diagnosis and a better prognosis for many rare diseases. […]
Barriers to Genetic Counseling for HCM: Q&A with Bryana Rivers, LGC
HCM is a disorder in which we observe thickening of the cardiac, or heart, muscle. As clinical screenings have improved over time, we noticed that HCM is a common condition that is underdiagnosed because many people who have the condition don’t present any clear symptoms. However, in diagnosed people, we noticed that roughly 40% to […]
Why Clinicians Should Care About PDABs
Q. Why should clinicians have a say on medication value? Clinicians, not PDABs or manufacturers, prescribe medications. We are the ones sitting with patients, evaluating, discussing and deciding which therapy would be best for them. PDAB “affordability” decisions are based on economics, not patient needs or outcomes. Read Q&A with Harry L. Gewanter, MD, FAAP, […]
Biologics in Respiratory Care
Q. How can biologics improve respiratory conditions? Biologics target the specific inflammatory pathways involved in the development of asthma, allergic diseases and other respiratory illnesses. This specificity allows for personalized treatment options because biologics attack different root causes of each disease. Read Q&A with James Tracy, DO >
Why is Lung Cancer Screening Crucial?
Jeffrey Velotta, MD, FACS, discusses the importance of screening for lung cancer. Read Q&A >
